The cover illustrates an inhalable virus-like-particle vaccine made of exosomes derived from lung cells and decorated with a recombinant SARS-CoV-2 receptor-binding domain.
Image: Kate Zvorykina. Cover design: Alex Wing.
An inhalable virus-like-particle vaccine against COVID-19
An inhalable virus-like-particle consisting of exosomes decorated with a recombinant SARS-Cov-2 receptor-binding domain is stable at room temperature and elicits systemic and mucosal immune responses in small animals.
Published in
Bioengineering & Biotechnology
Chief Editor, Nature Biomedical Engineering, Nature Research
Subscribe to the Topic
Biotechnology
Life Sciences > Biological Sciences > Biotechnology
-
Nature Biomedical Engineering
This journal aspires to become the most prominent publishing venue in biomedical engineering by bringing together the most important advances in the discipline, enhancing their visibility, and providing overviews of the state of the art in each field.
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in